PRESS RELEASE published on 03/10/2026 at 11:14, 6 months ago Inside Information / Other news releases Press release on the statement of number of shares and voting rights in compliance with French commercial code and AMF regulations Voting Rights French Commercial Code Shares AMF Regulated Information
PRESS RELEASE published on 03/10/2026 at 11:14, 6 months ago Informations privilégiées / Autres communiqués Déclaration du nombre de droits de vote et d'actions au 10 mars 2026 conformément à la réglementation financière en vigueur Autorité Des Marchés Financiers Déclaration Droits De Vote Actions Réglementé
BRIEF published on 02/03/2026 at 08:35, 7 months 8 days ago Arkema et Senior collaborent sur les matériaux de batteries de nouvelle génération Innovation Collaboration Matériaux De Batterie ARKEMA Senior
BRIEF published on 02/03/2026 at 08:35, 7 months 8 days ago Arkema et Senior unissent leurs forces pour innover dans les batteries Innovations Coopération Batteries ARKEMA Senior
BRIEF published on 02/03/2026 at 08:35, 7 months 8 days ago Arkema and Senior join forces to innovate in batteries Innovations Coopération Batteries ARKEMA Senior
BRIEF published on 02/03/2026 at 08:35, 7 months 8 days ago Arkema and Senior Collaborate on Next-Gen Battery Materials Innovation Collaboration Battery Materials ARKEMA Senior
PRESS RELEASE published on 02/03/2026 at 08:30, 7 months 8 days ago Informations privilégiées / Autres communiqués Arkema et Senior renforcent leur coopération pour le développement des matériaux pour batteries de nouvelle génération, visant l'innovation et la croissance du secteur des énergies nouvelles Innovation Coopération ARKEMA Senior Matériaux Pour Batteries
PRESS RELEASE published on 02/03/2026 at 08:30, 7 months 8 days ago Inside Information / Other news releases Arkema and Senior strengthen cooperation to advance next-generation battery materials through a strategic collaboration focusing on innovative material solutions for batteries in the global new energy sector Innovation Battery Materials Coopération ARKEMA Senior
BRIEF published on 02/02/2026 at 09:35, 7 months 9 days ago Arkema reçoit la médaille d'or EcoVadis pour son excellence en matière de développement durable Développement Durable EcoVadis RSE ARKEMA Médaille D'or
BRIEF published on 02/02/2026 at 09:35, 7 months 9 days ago Arkema Earns EcoVadis Gold Medal for Sustainability Excellence Sustainable Development EcoVadis CSR ARKEMA Gold Medal
Published on 09/11/2026 at 04:00, 6 hours 38 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 12 hours 13 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 19 hours 18 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 19 hours 38 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 10:15, 23 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 09:20, 1 hour 18 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 1 hour 32 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 1 hour 38 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 3 hours 38 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 3 hours 38 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 3 hours 38 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 15 hours 8 minutes ago Availability of the 2026 Interim Financial Report
